Steno Diabetes Center
Research facility
Location:
Gentofte,
Denmark (DK)
ISNI: 0000000406467285
ROR: https://ror.org/03w7awk87
Show on Map:
EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER (2019)
Perkovic V, Bain S, Bakris G, Buse J, Gondolf T, Idorn T, Lausvig N, et al.
Conference contribution
Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation (2018)
Teumer A, Chaker L, Groeneweg S, Li Y, Di Munno C, Barbieri C, Schultheiss UT, et al.
Journal article
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial (2015)
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, et al.
Journal article
Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs? (2015)
Mann J, Rossing P, Wiecek A, Rosivall L, Mark P, Mayer G
Journal article
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy (2014)
Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, et al.
Journal article